Drimys winteri
Drimys winteri · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Drimys winteri is a remarkable botanical species known for its diverse range of therapeutic activities, including potent anticancer and antinociceptive properties. Scientific investigations into its bark extracts have highlighted the presence of key bioactive chemicals such as polygodial, astilbin, drimenol, and isodrimenin. These compounds contribute to the plant's ability to act as a 11B-HSD-inhibitor and a 5-lipoxygenase-inhibitor, offering significant potential in managing various health conditions. Specifically, the bark ethyl acetate extract demonstrates strong antioxidant activity which is useful in combating cancer and reducing fevers. Through various preparations, this plant continues to serve as a vital subject for pharmacological research into treating complex diseases.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Winteraceae
- Distribution
- Africa
- Plant Parts
- Not available
Classification
Common Names
Drimys winteri is a versatile plant recognized by a diverse array of regional names across different cultures. It is widely known by the common names Canela-amarga and Canelo, reflecting its aromatic qualities. In certain areas, it is also referred to as Cannelle de Magellan, highlighting its unique botanical identity. Local traditions further identify the species as Capororoca-picante or Carne-d'anta. These various monikers showcase the deep connection between the plant and the people who utilize it.
Sources: Catalogue of Life (COL)
Taxonomy
Drimys winteri is a fascinating botanical specimen that belongs to the kingdom Plantae. Within this vast kingdom, the species is classified under the class Equisetopsida. It further falls into the order Canellales, showcasing its unique evolutionary lineage. The plant is a distinguished member of the genus Drimys, which defines its specific structural characteristics. Finally, it is nested within the Winteraceae family, completing its complex biological identity.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Canellales |
| Family | Winteraceae |
| Genus | Drimys |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Drimys winteri is a resilient plant species primarily distributed throughout the vast landscapes of Southern America. Its natural range extends deep into Southern South America, establishing a strong presence across diverse ecological zones. Within Argentina, the plant can be found thriving in the southern reaches of the country. The distribution continues northward into Chile, where it populates both the central and southern regions. This wide geographical spread highlights the plant's ability to adapt to various southern climates.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Drimys winteri is a distinctive tree that grows as a sturdy, self-supporting plant. This species typically reaches a moderate size, with a maximum height generally ranging between 7.5 and 10 meters. Its robust structure allows it to stand firmly within its natural habitat. Overall, this growth form makes it a notable feature of its ecosystem.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Drimys winteri is a medicinal plant traditionally used in folk medicine to treat a wide variety of ailments, including fevers, respiratory issues, and various pains. Recent scientific studies have validated these traditional uses by highlighting the plant's significant anticancer activities, particularly its ability to induce apoptosis in human melanoma cells. Research indicates that specific components such as polygodial and drimenol are highly effective at reducing cell viability and inhibiting tumor growth. Beyond its potential in oncology, the plant also demonstrates notable antinociceptive properties that help alleviate pain. In fact, certain compounds isolated from its bark have shown an antinociceptive potency that exceeds that of common drugs like aspirin and acetaminophen.
Compounds
Drimys winteri is a native Chilean medicinal tree that contains a diverse array of bioactive compounds within its bark. Scientific analysis has identified several key constituents, including the drimane sesquiterpenes polygodial, drimenol, isodrimenin, and isodrimeninol. Additionally, the plant is known to contain astilbin, a component that contributes to its complex chemical profile. These specific substances are responsible for the tree's notable pharmacological properties, ranging from antinociceptive effects to anti-atherosclerotic activity. Ultimately, the presence of these compounds reinforces the traditional medicinal importance of Drimys winteri in treating various inflammatory and infectious conditions.
Conditions
Drimys winteri provides significant biological benefits through its ability to treat the "take-all" disease by acting against the soilborne pathogen Gaeumannomyces graminis var. tritici. The plant's natural compounds also demonstrate potent anti-inflammatory properties by increasing the expression of the anti-inflammatory cytokine IL-10. Furthermore, its extracts and isolated sesquiterpenoids work to treat inflammation by significantly reducing the expression of the pro-inflammatory cytokine IL-1β. In the context of aquaculture, the plant serves as an immunomodulatory aid to help treat Saprolegniosis caused by Saprolegnia parasitica. These diverse therapeutic actions highlight the plant's potential as a versatile natural agent for both agricultural and medicinal applications.
Preparations
Drimys winteri is prepared as bark to isolate various bioactive compounds, such as drimane sesquiterpenoids. This plant is prepared as bark ethyl acetate extract to investigate its potential anticancer properties against human melanoma cells. Researchers also utilize Drimys winteri prepared as bark extract to evaluate its immunomodulatory effects in aquaculture settings. Additionally, the plant is prepared as extracts to test for inhibitory activity against parasites like Trypanosoma cruzi. Finally, Drimys winteri is prepared as the total extract of barks to study its ability to inhibit foam cell formation in macrophages.